• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 8
  3. Author

Online ISSN: 2515-8260

Volume7, Issue8

IN SILICO DESIGN, PREDICTION OF DRUG-LIKENESS AND TOXICITY OF NOVEL 3-(SUBSTITUTED PHENYL)-2-[5-(PYRIDIN-3-YL)-1,3,4-OXADIAZOL-2-YL]ACRYLONITRILES

    Madhavi Kuchana, Renuka Swathi Gonam

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 5502-5510

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

- A series of novel 3-(substituted phenyl)-2-[5-(pyridin-3-yl)-1,3,4-oxadiazol-2-yl]acrylonitriles were designed computationally based on the therapeutic benefits of 1,3,4-oxadiazole, nicotinoyl and arylacrylonitrile derivatives. The drug-likeness of title compounds were predicted by calculating molecular properties using Molinspiration Cheminformatics and OSIRIS Property Explorer. In addition, the bioactivity score and toxicity of all the compounds were estimated. The results of in silico screening indicated that all the compounds obeyed the Lipinski’s rule of five indicating good oral bioavailability. All the evaluated title compounds were identified as kinase inhibitors. The drug-likeness and drug score of the title compounds were good. Among all, compound with trimethoxy substitution on phenyl ring showed highest drug score.
Keywords:
  • PDF (1065 K)
  • XML
(2021). IN SILICO DESIGN, PREDICTION OF DRUG-LIKENESS AND TOXICITY OF NOVEL 3-(SUBSTITUTED PHENYL)-2-[5-(PYRIDIN-3-YL)-1,3,4-OXADIAZOL-2-YL]ACRYLONITRILES. European Journal of Molecular & Clinical Medicine, 7(8), 5502-5510.
Madhavi Kuchana, Renuka Swathi Gonam. "IN SILICO DESIGN, PREDICTION OF DRUG-LIKENESS AND TOXICITY OF NOVEL 3-(SUBSTITUTED PHENYL)-2-[5-(PYRIDIN-3-YL)-1,3,4-OXADIAZOL-2-YL]ACRYLONITRILES". European Journal of Molecular & Clinical Medicine, 7, 8, 2021, 5502-5510.
(2021). 'IN SILICO DESIGN, PREDICTION OF DRUG-LIKENESS AND TOXICITY OF NOVEL 3-(SUBSTITUTED PHENYL)-2-[5-(PYRIDIN-3-YL)-1,3,4-OXADIAZOL-2-YL]ACRYLONITRILES', European Journal of Molecular & Clinical Medicine, 7(8), pp. 5502-5510.
IN SILICO DESIGN, PREDICTION OF DRUG-LIKENESS AND TOXICITY OF NOVEL 3-(SUBSTITUTED PHENYL)-2-[5-(PYRIDIN-3-YL)-1,3,4-OXADIAZOL-2-YL]ACRYLONITRILES. European Journal of Molecular & Clinical Medicine, 2021; 7(8): 5502-5510.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 13
  • PDF Download: 19
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus